Drugs / chitosan-N-acetylcysteine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01753752 | Sep 2012 → Mar 2013 | dry eye syndrome | Gerhard Garhofer | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chitosan-N-acetylcysteine | “Recently, Croma Pharma has introduced chitosan-N-acetylcysteine eye drops, designed for treatment of symptoms related to DES.” NCT01753752 ↗ |